John Kaufmann
Direttore Finanziario/CFO presso S1 BioPharma, Inc.
Profilo
John F.
Kaufmann is currently the Chief Financial Officer at S1 BioPharma, Inc. He completed his undergraduate degree at Dartmouth College and holds an MBA from Boston University.
Posizioni attive di John Kaufmann
| Società | Posizione | Inizio |
|---|---|---|
S1 BioPharma, Inc.
 S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Direttore Finanziario/CFO | 12/04/2012 |
Formazione di John Kaufmann
| Boston University | Masters Business Admin |
| Dartmouth College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
S1 BioPharma, Inc.
S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- John Kaufmann
